Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases.

Kwon YM, Stammnitz MR, Wang J, Swift K, Knowles GW, Pye RJ, Kreiss A, Peck S, Fox S, Pemberton D, Jones ME, Hamede R, Murchison EP.

R Soc Open Sci. 2018 Oct 3;5(10):180870. doi: 10.1098/rsos.180870. eCollection 2018 Oct.

2.

The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.

Caldwell A, Coleby R, Tovar C, Stammnitz MR, Kwon YM, Owen RS, Tringides M, Murchison EP, Skjødt K, Thomas GJ, Kaufman J, Elliott T, Woods GM, Siddle HV.

Elife. 2018 Aug 14;7. pii: e35314. doi: 10.7554/eLife.35314.

3.

The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils.

Stammnitz MR, Coorens THH, Gori KC, Hayes D, Fu B, Wang J, Martin-Herranz DE, Alexandrov LB, Baez-Ortega A, Barthorpe S, Beck A, Giordano F, Knowles GW, Kwon YM, Hall G, Price S, Pye RJ, Tubio JMC, Siddle HVT, Sohal SS, Woods GM, McDermott U, Yang F, Garnett MJ, Ning Z, Murchison EP.

Cancer Cell. 2018 Apr 9;33(4):607-619.e15. doi: 10.1016/j.ccell.2018.03.013.

4.

scanPAV: a pipeline for extracting presence-absence variations in genome pairs.

Giordano F, Stammnitz MR, Murchison EP, Ning Z.

Bioinformatics. 2018 Sep 1;34(17):3022-3024. doi: 10.1093/bioinformatics/bty189.

5.

Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.

Agne M, Blank I, Emhardt AJ, Gäbelein CG, Gawlas F, Gillich N, Gonschorek P, Juretschke TJ, Krämer SD, Louis N, Müller A, Rudorf A, Schäfer LM, Scheidmann MC, Schmunk LJ, Schwenk PM, Stammnitz MR, Warmer PM, Weber W, Fischer A, Kaufmann B, Wagner HJ, Radziwill G.

ACS Synth Biol. 2014 Dec 19;3(12):986-9. doi: 10.1021/sb500035y.

PMID:
25524106

Supplemental Content

Loading ...
Support Center